Renaissance Technologies - IO BIOTECH INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of IO BIOTECH INC
ValueSharesWeighting
Q3 2023$34
-74.8%
24,386
-64.7%
0.00%
Q2 2023$135
+16.4%
69,100
+12.0%
0.00%
Q1 2023$116
+107.1%
61,700
+155.0%
0.00%
Q4 2022$56
-99.9%
24,200
+31.4%
0.00%
Q3 2022$50,00018,4230.00%
Other shareholders
IO BIOTECH INC shareholders Q4 2023
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 3,640,015$5,132,4211.57%
Vivo Capital, LLC 6,173,439$8,704,5490.95%
Stonepine Capital Management, LLC 1,975,308$2,785,1840.92%
Novo Holdings A/S 5,747,067$8,103,3640.60%
Pivotal bioVenture Partners Investment Advisor LLC 864,197$1,218,5180.49%
Logos Global Management LP 493,827$696,2960.09%
PFM Health Sciences, LP 1,353,453$1,908,3690.09%
ARMISTICE CAPITAL, LLC 2,148,000$3,028,6800.05%
Avoro Capital Advisors LLC 2,055,883$2,837,1190.04%
Alyeska Investment Group, L.P. 987,654$1,392,5920.01%
View complete list of IO BIOTECH INC shareholders